Emergent BioSolutions Inc (EBS)

28.12
0.49 1.80
NYSE : Health Care
Prev Close 27.63
Open 27.36
Day Low/High 27.36 / 28.23
52 Wk Low/High 26.53 / 44.38
Volume 106.58K
Avg Volume 844.00K
Exchange NYSE
Shares Outstanding 40.46M
Market Cap 1.12B
EPS 1.60
P/E Ratio 16.83
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent BioSolutions; Reminds Investors Of September 19, 2016 Deadline

SHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent BioSolutions; Reminds Investors Of September 19, 2016 Deadline

Holzer & Holzer, LLC has filed a securities class against lawsuit against Emergent BioSolutions, Inc.

Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Emergent BioSolutions, Inc. Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Emergent BioSolutions, Inc. Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors who purchased Emergent BioSolutions, Inc.

SHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors Of Important Deadline In Class Action

SHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors Of Important Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Emergent Biosolutions, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Emergent Biosolutions, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Maryland, Southern Division,...

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC (the "Firm") announces a class action lawsuit has been filed against Emergent BioSolutions, Inc.

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Emergent BioSolutions, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Emergent BioSolutions, Inc.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Emergent BioSolutions, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Emergent BioSolutions, Inc.

EBS March 2017 Options Begin Trading

EBS March 2017 Options Begin Trading

Investors in Emergent BioSolutions Inc saw new options begin trading today, for the March 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.